BeStock  
Markets › Compare › IMCDY vs RYTM

IMCDY vs RYTM

Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.

vsvs
IMCDY · IMCD NV UNSP ADR EACH REP 0.50 ORD$53.45 ▼ 0.65%
RYTM · Rhythm Pharmaceuticals$92.45 ▼ 0.41%

One year, rebased to 100

Each line starts at 100 so growth is directly comparable

728496108120Oct 7, '25Apr 7, '26Oct 5, '26
  • IMCDY +1.4%
  • RYTM -7.4%

Head to head

MetricIMCDYRYTM
Price$53.45$92.45
Change today▼ 0.65%▼ 0.41%
Market cap$6.37B$6.37B
Return, 3 months+12.7%-19.2%
Return, year to date+20.3%-13.6%
Return, 1 year+0.7%-5.5%
P/E (TTM)23.5-29.6
P/B2.661.8
P/E percentile vs own 5y––
Dividend yield1.97%–
Revenue growth (YoY, latest qtr)––
Net profit growth (YoY)––
Gross margin––
Operating margin––
Net margin––
Return on equity––
Analyst target vs. price––
Analyst buy share––
RSI (14)4229
30-day volatility23.0%28.6%
Max drawdown, 1 year-29.2%-35.5%
Trend readLeaning bearishStrong downtrend
Analyst consensus––

Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.

What the numbers say

  • IMCDY is the largest of the group by market value.
  • IMCDY has returned the most over the past year.
  • RYTM carries the lowest trailing P/E.
  • IMCDY has been the calmest stock over the last 30 days.

Go deeper

Scroll to Top